ORIG3N, a leader in regenerative medicine technology and consumer genetics assessments, has unveiled two new DNA tests focused exclusively on individuals' future development. The Company's DNA tests are designed to reveal genetic information that will remove some of the roadblocks along the path to optimal health. This will ease the frustration consumers often feel when identifying what will work best for their unique sensitivities, behavioral factors and more.
With ORIG3N's DNA tests customers can confirm things they always suspected about themselves, and discover things they never knew.
Latest funding size
Time since last funding
|9 months ago|
|Spectrum Health Ventures, DEFTA Partners, Mountain Group Capital, Syno Capital, Harris & Harris Group, KTB Ventures, KTB-KORUS Fund, 180 Degree Capital, Hatteras Venture Partners, LabCorp, MGC Venture Partners|